NCT00317343撤回不适用
RIAPRE - A Non-interventional Registry on the Anticoagulation Treatment in High Risk Elective Percutaneous Coronary Interventions
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Nycomed
研究概览
简要总结
RIAPRE is a non-interventional registry to be settled in Italy with the purpose of collecting data on 600 cases of high risk elective percutaneous coronary intervention (PCI) patients treated with an anticoagulation regime different from unfractionated heparin in monotherapy. About thirty catheterization laboratories will co-operate in this activity. The long term outcome of patients will be taken into consideration. The availability of these data will allow for a better understanding of the therapeutic needs in this area.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •There will be no specific exclusion criteria other than those listed in the Summary of Product Characteristics of every individual agent.
研究者
相似试验
已完成
不适用
A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.Multiple MyelomaNCT02164955Celgene775
已完成
不适用
The REAL Registry for Utilization of iFR in Assessing Coronary StenosesCoronary DiseaseNCT02281110Volcano Corporation500
撤回
不适用
PREHEVBRIO Pregnancy Outcomes RegistryVaccine Exposure During PregnancyNCT06097312VBI Vaccines Inc.120
招募中
不适用
The PROTECT-EU StudyHigh-risk PCINCT05466552Fondazione GISE Onlus859
招募中
不适用
Registry for Patients With X-Linked HypophosphatemiaX-Linked HypophosphatemiaNCT03193476Kyowa Kirin Pharmaceutical Development Ltd1,489
